Intelligent Bio Solutions Inc. (NASDAQ:INBS) Sees Significant Increase in Short Interest

Intelligent Bio Solutions Inc. (NASDAQ:INBS) saw a large increase in short interest in March. As of March 31st, there was short interest totalling 538,900 shares, an increase of 19.1% from the March 15th total of 452,300 shares. Based on an average trading volume of 206,300 shares, the days-to-cover ratio is currently 2.6 days. Approximately 8.1% of the shares of the company are short sold.

Intelligent Bio Solutions Stock Performance

Shares of INBS stock traded up $0.03 on Tuesday, hitting $1.24. 21,598 shares of the stock traded hands, compared to its average volume of 545,314. Intelligent Bio Solutions has a 1-year low of $1.00 and a 1-year high of $3.04. The company’s fifty day moving average is $1.83 and its 200 day moving average is $1.64.

Intelligent Bio Solutions (NASDAQ:INBS) last posted its earnings results on Thursday, February 13th. The company reported ($0.50) EPS for the quarter. Intelligent Bio Solutions had a negative net margin of 323.79% and a negative return on equity of 146.03%. The business had revenue of $610 billion during the quarter. As a group, equities research analysts predict that Intelligent Bio Solutions will post -1.25 EPS for the current year.

Intelligent Bio Solutions Company Profile

Intelligent Bio Solutions Inc, a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.